Literature DB >> 29340339

Other Estimation of Blood Losses in Hemodialysis and Formula for Translating Liver Iron Concentration From Iron Balance Calculation Based on Iron Removal by Phlebotomy.

Jacques Rottembourg1.   

Abstract

Entities:  

Year:  2017        PMID: 29340339      PMCID: PMC5762975          DOI: 10.1016/j.ekir.2017.11.012

Source DB:  PubMed          Journal:  Kidney Int Rep        ISSN: 2468-0249


× No keyword cloud information.
To the Editor: In his recent editorial, Daniel Coyne raises concerns regarding iron overload detection in dialysis patients by quantitative magnetic resonance imaging (MRI). Using the equation established by Barry in 1974 (based on the relationship between liver iron content [LIC] and stored iron mobilized by phlebotomy in 12 patients with genetic hemochromatosis, where 30 μmol/g dry liver LIC equals 1 g of iron), Daniel Coyne calculates that the decline in LIC on MRI found by Rostoker et al. in their iron-overloaded hemodialysis patients after iron withdrawal (17.9 μmol/g dry liver/month or 215 μmol/g dry liver per year) “cannot match blood losses (7.16 g of iron lost per year with Barry’s formula).” I recently conducted an in-depth review of blood loss in hemodialysis patients; these are related to the hemodialysis procedure itself, to routine blood sampling for laboratory tests, and to occult gastrointestinal bleeding due to uremic enteropathy. In dialysis patients with a native fistula, iron losses are 1340 mg per year compared with 2765 mg per year in patients with a long-lasting double-lumen catheter; these losses are increased by antiplatelet drugs and vitamin K antagonists (703–961 mg of additional iron lost). With the widely used formula of Brissot et al. (based on the relationship between LIC and phlebotomy in 29 cases of genetic hemochromatosis in which 130 μmol/g dry liver LIC equals 1 g of iron), the yearly decrease in LIC found by Rostoker et al. (270 μmol/g per year, corresponding to 1680 mg of iron per year) fits fairly well with usual blood losses in hemodialysis patients.
  5 in total

1.  Liver iron concentration, stainable iron, and total body storage iron.

Authors:  M Barry
Journal:  Gut       Date:  1974-05       Impact factor: 23.059

2.  Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study.

Authors:  Guy Rostoker; Mireille Griuncelli; Christelle Loridon; Renaud Couprie; Abbes Benmaadi; Catherine Bounhiol; Myriam Roy; Gabrielle Machado; Phillippe Janklewicz; Gilles Drahi; Hervé Dahan; Yves Cohen
Journal:  Am J Med       Date:  2012-10       Impact factor: 4.965

3.  Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods.

Authors:  P Brissot; M Bourel; D Herry; J P Verger; M Messner; C Beaumont; F Regnouard; B Ferrand; M Simon
Journal:  Gastroenterology       Date:  1981-03       Impact factor: 22.682

Review 4.  [Use of intravenous iron supplementation in chronic kidney disease: Interests, limits, and recommendations for a better practice].

Authors:  Jacques Rottembourg; Guy Rostoker
Journal:  Nephrol Ther       Date:  2015-10-20       Impact factor: 0.722

5.  Iron Overload in Dialysis Patients: Rust or Bust?

Authors:  Daniel W Coyne
Journal:  Kidney Int Rep       Date:  2017-09-01
  5 in total
  1 in total

1.  Pharmacokinetics of ferric pyrophosphate citrate administered via dialysate and intravenously to pediatric patients on chronic hemodialysis.

Authors:  Raymond D Pratt; Sarah Grimberg; Joshua J Zaritsky; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2018-07-12       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.